22nd Century Group logo
22nd Century Group XXII
$ 1.95 -4.65%

Annual report 2025
added 03-26-2026

report update icon

22nd Century Group Long Term Debt Current 2011-2026 | XXII

Annual Long Term Debt Current 22nd Century Group

2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
168 K 261 K 231 K 252 K 308 K 247 K 220 K - - - - - - - -

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
308 K 168 K 241 K

Long Term Debt Current of other stocks in the Biotechnology industry

Issuer Long Term Debt Current Price % 24h Market Cap Country
MorphoSys AG MorphoSys AG
MOR
3.63 M - 2.43 % $ 254 M germanyGermany
Alterity Therapeutics Limited Alterity Therapeutics Limited
ATHE
57.6 K $ 4.23 6.55 % $ 10.2 B australiaAustralia
Adverum Biotechnologies Adverum Biotechnologies
ADVM
5.67 M - - $ 86.2 M usaUSA
Akouos Akouos
AKUS
671 K - 0.23 % $ 488 M usaUSA
I-Mab I-Mab
IMAB
8.06 M - - $ 866 M chinaChina
AlloVir AlloVir
ALVR
316 K - 4.14 % $ 49.1 M usaUSA
Aligos Therapeutics Aligos Therapeutics
ALGS
3.58 M $ 6.98 -8.88 % $ 69 M usaUSA
Allakos Allakos
ALLK
3.25 M - - $ 28.6 M usaUSA
Alnylam Pharmaceuticals Alnylam Pharmaceuticals
ALNY
45.5 M $ 319.0 -0.35 % $ 41.8 B usaUSA
Applied Molecular Transport Applied Molecular Transport
AMTI
4.64 M - - $ 10.1 M usaUSA
Amphastar Pharmaceuticals Amphastar Pharmaceuticals
AMPH
7.93 M $ 22.02 0.96 % $ 1.03 B usaUSA
Applied Therapeutics Applied Therapeutics
APLT
429 K - - $ 8.42 M usaUSA
BioNTech SE BioNTech SE
BNTX
45 M $ 103.6 1.45 % $ 27.2 B germanyGermany
Aptinyx Aptinyx
APTX
337 K - -39.0 % $ 4.57 M usaUSA
Aravive Aravive
ARAV
2.2 M - -13.39 % $ 1.45 M usaUSA
Advaxis Advaxis
ADXS
166 K - -9.65 % $ 45.9 M usaUSA
Aeterna Zentaris Aeterna Zentaris
AEZS
215 K - 5.93 % $ 314 M canadaCanada
AgeX Therapeutics AgeX Therapeutics
AGE
181 K - -10.17 % $ 12.2 K usaUSA
BioXcel Therapeutics BioXcel Therapeutics
BTAI
65 K $ 1.15 7.47 % $ 14 M usaUSA
Aeglea BioTherapeutics Aeglea BioTherapeutics
AGLE
625 K - - $ 1.01 B usaUSA
Akebia Therapeutics Akebia Therapeutics
AKBA
3.55 M $ 1.35 -0.74 % $ 347 M usaUSA
Ayala Pharmaceuticals Ayala Pharmaceuticals
AYLA
419 K - - $ 7.46 M israelIsrael
Applied Genetic Technologies Corporation Applied Genetic Technologies Corporation
AGTC
1.27 M - - $ 26.5 M usaUSA
Aquestive Therapeutics Aquestive Therapeutics
AQST
631 K $ 4.33 1.64 % $ 463 M usaUSA
AstraZeneca PLC AstraZeneca PLC
AZN
382 M - - $ 96.9 B britainBritain
Arcutis Biotherapeutics Arcutis Biotherapeutics
ARQT
294 K $ 24.53 1.41 % $ 3.12 B usaUSA
AIkido Pharma AIkido Pharma
AIKI
554 K - 1.93 % $ 17.4 M usaUSA
Brainstorm Cell Therapeutics Brainstorm Cell Therapeutics
BCLI
208 K - -2.5 % $ 5.88 M usaUSA
Cabaletta Bio Cabaletta Bio
CABA
3.46 M $ 3.23 -8.24 % $ 325 M usaUSA
Can-Fite BioPharma Ltd. Can-Fite BioPharma Ltd.
CANF
43 K $ 2.94 -4.55 % $ 4.84 M israelIsrael
Autolus Therapeutics plc Autolus Therapeutics plc
AUTL
4.56 M $ 1.64 1.55 % $ 436 M britainBritain
Aptose Biosciences Aptose Biosciences
APTO
193 K - -45.71 % $ 1.2 M canadaCanada
AVROBIO AVROBIO
AVRO
878 K - 1083.1 % $ 745 M usaUSA
BeiGene, Ltd. BeiGene, Ltd.
BGNE
20.7 M - 0.49 % $ 251 B cayman-islandsCayman-islands
bluebird bio bluebird bio
BLUE
21.2 M - - $ 546 M usaUSA
CureVac N.V. CureVac N.V.
CVAC
3.47 M - - $ 867 M germanyGermany
Cidara Therapeutics Cidara Therapeutics
CDTX
1.38 M - - $ 1.41 B usaUSA
Celldex Therapeutics Celldex Therapeutics
CLDX
1.55 M $ 34.74 2.6 % $ 2.31 B usaUSA
CymaBay Therapeutics CymaBay Therapeutics
CBAY
7 K - - $ 3.45 B usaUSA
Allena Pharmaceuticals Allena Pharmaceuticals
ALNA
317 K - 3.16 % $ 1.9 M usaUSA